マイコプラズマ検査の世界市場2020-2026:製品・サービス別(試薬・キット、機器、サービス)、技術別、用途別、エンドユーザー別、地域別

◆英語タイトル:Global Mycoplasma Testing Market Size study, by Product & Services (Reagents & Kits, Instruments, Services), by Technique (Polymerase Chain Reaction (PCR), Elisa, Direct Assays, Indirect Assays, DNA Staining, Others), by Application (Cell Line Testing, Virus Testing, End-of-Production Cell Testing, Others), by End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Cell Banks, Others) and Regional Forecasts 2020-2026
◆商品コード:BZW20JN001
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年4月25日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥650,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、マイコプラズマ検査の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、製品・サービス別(試薬・キット、機器、サービス)分析、技術別分析、用途別分析、エンドユーザー別分析、地域別分析、競争状況などを含め、次の構成でお届け致します。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・マイコプラズマ検査の世界市場:製品・サービス別(試薬・キット、機器、サービス)
・マイコプラズマ検査の世界市場:技術別
・マイコプラズマ検査の世界市場:用途別
・マイコプラズマ検査の世界市場:エンドユーザー別
・マイコプラズマ検査の世界市場:地域別
・競争状況
【レポートの概要】

Global Mycoplasma Testing Market is valued approximately USD 662 million in 2019 and is anticipated to grow with a healthy growth rate of more than 12.5% over the forecast period 2020-2026. Mycoplasma is referred to as the class of bacteria commonly present in cell culture. It is also known as mollicutes, these bacteria require a cell wall, which make them impervious to frequently use antibiotics, such as penicillin. Mycoplasma is easily spread via droplets throughout cell culture and can persist in dried form for months. Mycoplasma infection is complex to see with a microscope and involves specific testing, to be detected. Infection can have an acute impact on experimental work reliant on the species present. Mycoplasma organisms can affect cell growth, tumorigenicity, metabolism and response to chemotherapy. Rising research activities conducted by pharmaceutical and biotechnology companies, increased government support and funding in research activities, and growing cell culture contamination around the world are the few factors responsible for high CAGR of the market over the forecast period. For instance, in 2018, Boehringer Ingelheim, a pharmaceutical company, has announced its plans to invest almost $259 million for its novel Biologicals Development Center (BDC), to be sited as a R&D hub in Germany. Similarly, Merck KGaA is also planning to invest around $16 billion in R&D over the next five years, in addition to its yearly investment of $7 billion. Therefore, a huge amount of investments in R&D activities, is expected to drive the demand for mycoplasma testing products around the world. However, high degree of consolidation acts and stringent regulatory framework are the few factors expected to hamper the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Mycoplasma Testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the expanding healthcare expenditure and rising investments by the U.S. government to enhance research-based activities in biopharmaceutical industries. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to regulatory policies enacted by healthcare organizations for improving biosafety quality in the countries like China and India.

Major market player included in this report are:
Charles River Laboratories International, Inc.
Merck KGaA
Lonza Group Ltd.
Roche Diagnostics (Division of F. Hoffman-La Roche Ltd.)
Thermo Fisher Scientific Inc.
American Type Culture Collection
Biounique Testing Laboratories Inc.
Invivogen
Promocell GmbH
Biological Industries Israel Beit Haemek Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product & Services:
Reagents & Kits
Instruments
Services & Software

By Technique:
Polymerase Chain Reaction (PCR)
Elisa
Direct Assays
Indirect Assays
DNA Staining
Others

By Application:
Cell Line Testing
Virus Testing
End-of-Production Cell Testing
Others

By End-User:
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic Research Institutes
Cell Banks
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026

Target Audience of the Global Mycoplasma Testing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million)
1.2.1. Mycoplasma Testing Market, by Region, 2018-2026 (USD Million)
1.2.2. Mycoplasma Testing Market, by Product & Services, 2018-2026 (USD Million)
1.2.3. Mycoplasma Testing Market, by Technique, 2018-2026 (USD Million)
1.2.4. Mycoplasma Testing Market, by Application, 2018-2026 (USD Million)
1.2.5. Mycoplasma Testing Market, by End-User, 2018-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Mycoplasma Testing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Mycoplasma Testing Market Dynamics
3.1. Mycoplasma Testing Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Mycoplasma Testing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Mycoplasma Testing Market, by Product & Services
5.1. Market Snapshot
5.2. Global Mycoplasma Testing Market by Product & Services, Performance – Potential Analysis
5.3. Global Mycoplasma Testing Market Estimates & Forecasts by Product & Services 2016-2026 (USD Million)
5.4. Mycoplasma Testing Market, Sub Segment Analysis
5.4.1. Reagents & Kits
5.4.2. Instruments
5.4.3. Services
Chapter 6. Global Mycoplasma Testing Market, by Technique
6.1. Market Snapshot
6.2. Global Mycoplasma Testing Market by Technique, Performance – Potential Analysis
6.3. Global Mycoplasma Testing Market Estimates & Forecasts by Technique 2016-2026 (USD Million)
6.4. Mycoplasma Testing Market, Sub Segment Analysis
6.4.1. Polymerase Chain Reaction (PCR)
6.4.2. Elisa
6.4.3. Direct Assays
6.4.4. Indirect Assays
6.4.5. DNA Staining
6.4.6. Others
Chapter 7. Global Mycoplasma Testing Market, by Application
7.1. Market Snapshot
7.2. Global Mycoplasma Testing Market by Application, Performance – Potential Analysis
7.3. Global Mycoplasma Testing Market Estimates & Forecasts by Application 2016-2026 (USD Million)
7.4. Mycoplasma Testing Market, Sub Segment Analysis
7.4.1. Cell Line Testing
7.4.2. Virus Testing
7.4.3. End-of-Production Cell Testing
7.4.4. Others
Chapter 8. Global Mycoplasma Testing Market, by End-User
8.1. Market Snapshot
8.2. Global Mycoplasma Testing Market by End-User, Performance – Potential Analysis
8.3. Global Mycoplasma Testing Market Estimates & Forecasts by End-User 2016-2026 (USD Million)
8.4. Mycoplasma Testing Market, Sub Segment Analysis
8.4.1. Pharmaceutical and Biotechnology Companies
8.4.2. Contract Research Organizations
8.4.3. Academic Research Institutes
8.4.4. Cell Banks
8.4.5. Others
Chapter 9. Global Mycoplasma Testing Market, Regional Analysis
9.1. Mycoplasma Testing Market, Regional Market Snapshot
9.2. North America Mycoplasma Testing Market
9.2.1. U.S. Mycoplasma Testing Market
9.2.1.1. Product & Services breakdown estimates & forecasts, 2016-2026
9.2.1.2. Technique breakdown estimates & forecasts, 2016-2026
9.2.1.3. Application breakdown estimates & forecasts, 2016-2026
9.2.1.4. End-User breakdown estimates & forecasts, 2016-2026
9.2.2. Canada Mycoplasma Testing Market
9.3. Europe Mycoplasma Testing Market Snapshot
9.3.1. U.K. Mycoplasma Testing Market
9.3.2. Germany Mycoplasma Testing Market
9.3.3. Rest of Europe Mycoplasma Testing Market
9.4. Asia-Pacific Mycoplasma Testing Market Snapshot
9.4.1. China Mycoplasma Testing Market
9.4.2. India Mycoplasma Testing Market
9.4.3. Japan Mycoplasma Testing Market
9.4.4. Rest of Asia Pacific Mycoplasma Testing Market
9.5. Latin America Mycoplasma Testing Market Snapshot
9.5.1. Brazil Mycoplasma Testing Market
9.5.2. Mexico Mycoplasma Testing Market
9.6. Rest of The World Mycoplasma Testing Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Charles River Laboratories International, Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Merck KGaA
10.2.3. Lonza Group Ltd.
10.2.4. Roche Diagnostics (Division of F. Hoffman-La Roche Ltd.)
10.2.5. Thermo Fisher Scientific Inc.
10.2.6. American Type Culture Collection
10.2.7. Biounique Testing Laboratories Inc.
10.2.8. Invivogen
10.2.9. Promocell GmbH
10.2.10. Biological Industries Israel Beit Haemek Ltd.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

List of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL MYCOPLASMA TESTING MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL MYCOPLASMA TESTING MARKET
TABLE 3. GLOBAL MYCOPLASMA TESTING MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
TABLE 7. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY PRODUCT & SERVICES 2016-2026 (USD MILLION)
TABLE 8. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY TECHNIQUE 2016-2026 (USD MILLION)
TABLE 9. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD MILLION)
TABLE 10. GLOBAL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD MILLION)
TABLE 11. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 12. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 13. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 14. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 15. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 16. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 17. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 18. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 19. GLOBAL MYCOPLASMA TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 20. GLOBAL MYCOPLASMA TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 21. U.S. MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 22. U.S. MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 23. U.S. MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 24. CANADA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 25. CANADA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 26. CANADA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 27. UK MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 28. UK MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 29. UK MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 30. GERMANY MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 31. GERMANY MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 32. GERMANY MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 33. ROE MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 34. ROE MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 35. ROE MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 36. CHINA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 37. CHINA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 38. CHINA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 39. INDIA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 40. INDIA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 41. INDIA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 42. JAPAN MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 43. JAPAN MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 44. JAPAN MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 45. ROAPAC MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 46. ROAPAC MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 47. ROAPAC MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 48. BRAZIL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 49. BRAZIL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 50. BRAZIL MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 51. MEXICO MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 52. MEXICO MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 53. MEXICO MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 54. ROLA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 55. ROLA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 56. ROLA MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 57. ROW MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 58. ROW MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 59. ROW MYCOPLASMA TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[マイコプラズマ検査の世界市場2020-2026:製品・サービス別(試薬・キット、機器、サービス)、技術別、用途別、エンドユーザー別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆